|
Product Description
|
Recall Class
|
FDA Recall Posting Date
|
Recalling Firm
|
Z-1012-2024 - BD BBL Sensi Disc Ampicillin - 10 ®g, Catalog No. 230705 and 231264; 2 ®g, Catalog No. 231263. Used for semi-quantitative in vitro susceptibility testing.
|
2
|
02/08/2024
|
Becton Dickinson & Co.
|
Z-1013-2024 - BD BBL Sensi Disc Ampicillin with Sulbactam 10/10 ®g, Catalog Number 231660. Used for semi-quantitative in vitro susceptibility testing.
|
2
|
02/08/2024
|
Becton Dickinson & Co.
|
Z-1014-2024 - BD BBL Sensi Disc Augmentin - 3®g, Catalog Number 291270®used for semi-quantitative in vitro susceptibility testing.
|
2
|
02/08/2024
|
Becton Dickinson & Co.
|
Z-1015-2024 - BD BBL Sensi Disc Azithromycin -15 ®g, Catalog Number 231682®used for semi-quantitative in vitro susceptibility testing.
|
2
|
02/08/2024
|
Becton Dickinson & Co.
|
Z-1016-2024 - BD BBL Sensi Disc Aztreonam - 30 ug®, used for semi-quantitative in vitro susceptibility testing. Catalog Numbers 231640®and 231641.
|
2
|
02/08/2024
|
Becton Dickinson & Co.
|
Z-1017-2024 - BD BBL Sensi Disc Cefaclor - 30 ug®, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231653®
|
2
|
02/08/2024
|
Becton Dickinson & Co.
|
Z-1018-2024 - BD BBL Sensi Disc Cefepime - 30 ug®, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231696®
|
2
|
02/08/2024
|
Becton Dickinson & Co.
|
Z-1019-2024 - BD BBL Sensi Disc Cefixime - 5 ug®, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231664®
|
2
|
02/08/2024
|
Becton Dickinson & Co.
|
Z-1020-2024 - BD BBL Sensi Disc Cefotaxime - 30 ug®, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231606 and 231607®;
5 ug, Catalog No. 291308®
|
2
|
02/08/2024
|
Becton Dickinson & Co.
|
Z-1021-2024 - BD BBL Sensi Disc Cefpodoxime - 10 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231673 and 231674®
|
2
|
02/08/2024
|
Becton Dickinson & Co.
|